Point72 Asia (Singapore)’s Cytokinetics CYTK Stock Holding History

Point72 Asia (Singapore)’s Portfolio CYTK Stock Details CYTK Fund Activity

Bought

Maintained

Sold

Quarter	Market Value	Status	Shares	Change in Stake	Trade Value	Portfolio Weight	Portfolio Position
2025 Q3	$648K	Buy	+11,799	New	+$486K	0.1%	143
2025 Q1	–	Sell	-1,849	Closed	-$87K	–	942
2024 Q4	$87K	Buy	+1,849	New	+$96K	0.02%	399
2024 Q2	–	Sell	-13,965	Closed	-$979K	–	1131
2024 Q1	$979K	Buy	+13,965	New	+$1.08M	0.25%	85

Other funds holding CYTK

T. Rowe Price Investment Management Baltimore, Maryland $145B AUM 22.78% 1-Year Est. Return

BlackRock New York $5.72T AUM 30.48% 1-Year Est. Return

Fidelity Investments Boston, Massachusetts $1.9T AUM 41.92% 1-Year Est. Return

Vanguard Group Malvern, Pennsylvania $6.9T AUM 27.45% 1-Year Est. Return

Wellington Management Group Boston, Massachusetts $535B AUM 26.23% 1-Year Est. Return

State Street Boston, Massachusetts $2.9T AUM 29.55% 1-Year Est. Return

DTC

Deep Track Capital Greenwich, Connecticut $6.12B AUM 144% 1-Year Est. Return

Bank of America Charlotte, North Carolina $1.37T AUM 24.88% 1-Year Est. Return

Geode Capital Management Boston, Massachusetts $1.61T AUM 30.72% 1-Year Est. Return

PCH

Polar Capital Holdings London, United Kingdom $28.2B AUM 115.26% 1-Year Est. Return

Point72 Asia (Singapore)'s CYTK Position: Q3 2025 in Review

Point72 Asia (Singapore) opened a new position in Cytokinetics (CYTK) in Q3 2025: 11,799 shares worth $648K. The stake represents 0.1% of the portfolio and ranks #143 among its holdings. This is a return to the name: Point72 Asia (Singapore) previously reported a position in CYTK as recently as Q4 2024.

Point72 Asia (Singapore) first reported a position in CYTK in Q1 2024 and has held it in 3 quarters since. The position peaked at $979K in Q1 2024. 380 funds tracked by Wall St. Rank hold CYTK as of Q3 2025.

Point72 Asia (Singapore) held 11,799 shares of Cytokinetics worth $648K as of Q3 2025.
Cytokinetics was a new Point72 Asia (Singapore) position in Q3 2025.
Cytokinetics made up 0.1% of Point72 Asia (Singapore)'s portfolio in Q3 2025, its #143 holding.
Point72 Asia (Singapore) first reported a position in Cytokinetics in Q1 2024 and has held it in 3 quarters since.
Point72 Asia (Singapore)'s Cytokinetics position peaked at $979K in Q1 2024.
380 funds tracked by Wall St. Rank held Cytokinetics as of Q3 2025.

Based on Point72 Asia (Singapore)'s 13F filing for Q3 2025, filed 14 Nov 2025.